Latest Share Chat

REMOVE ADS

Fusion Antibodies Share News (FAB)

Fusion Antibodies Information

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes

Get Live Data

12.50 0.50 (4.17%)

Bid:

12.00

Ask:

13.00

Spread: 1.00 (8.333%)

Market Cap: £15.64m

Last checked at -

Intraday Fusion Antibodies Share Chart

REMOVE ADS

Fusion Antibodies News

EARNINGS AND TRADING: McBride restarts dividends after "solid" year

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Fusion Antibodies reports further validation of OptiMAL platform

(Sharecast News) - Fusion Antibodies reported further validation of its OptiMAL discovery platform on Wednesday, saying its collaboration with the US ...

EARNINGS: Gem Diamonds revenue down; Brooks Macdonald outflows ease

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...

TRADING UPDATES: Avingtrans HS2 win; Metals Exploration's Runruno blow

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Fusion Antibodies hails new contracts worth USD460,000

(Alliance News) - Fusion Antibodies PLC on Wednesday said it was selected to proceed with three follow on projects to the stable Cell Line Development...

Fusion Antibodies selected for follow-on projects

(Sharecast News) - Pre-clinical antibody discovery specialists Fusion Antibodies said on Wednesday that it has been selected for three follow-on proje...

TRADING UPDATES: Poolbeg upsizes offer; Glenveagh backs outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Fusion Antibodies validation project with US NIC progresses

(Sharecast News) - Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was progressi...